WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 05-Dec-2014 (Data received as of 1-Dec-2014)
Next overall update June 2015
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 6'7101 Infant (under 12 months) mortality rate: 282
GDP / capita (US$): 15'1881 Child (under 5 years) mortality rate: 342

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 33'765  32'778  31'837  30'962  30'163  23'801  17'518  13'653 
Births 1'052  1'037  1'022  1'008  994  854  666  545 
Surviving infants 1'023  1'007  992  977  962  824  642  518 
Pop. less than 5 years 4'909  4'824  4'747  4'682  4'602  3'865  3'017  2'435 
Pop. less than 15 years 13'526  13'262  13'006  12'766  12'491  10'187  8'036  6'395 
Female 15-49 years 8'338  8'037  7'748  7'477  7'257  5'636  3'846  2'793 

Number of reported case

(Click for retrospective incidence data for Iraq)
Diphtheria 13  34  10  1'122 
Japanese encephalitis
Measles 669  15  15  492  30'328  726  3'045  26'542 
Mumps 1'809  1'482  1'944  1'862  2'265  18'720 
Pertussis 2'471  2'314  2'019  2'034  5'471  407  122  16'687 
Polio* 56  997 
Rubella 30  22  18  15  167  1'612 
Rubella (CRS)
Tetanus (neonatal) 10  11  10  11  17  37  152  891 
Tetanus (total) 34  34  39  25  34  1'045 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Iraq)
Vaccine year result method % card seen                                                
BCG 2010  90  MICS   70  93  99*  69  86  99*  79  95  76 
DTP1 2010  86  MICS   70  89  95  97  93  100  92  91 
DTP3 2010  70  MICS   70  78  79  89  84  86  86  83  13 
HepB_BD          43  37  27  79 
HepB3 2010  66  MICS   70  78  73  89  84  86  67 
Hib3          78  46 
JapEnc         
MCV 2010  75  MICS   70  77  83  91  89  97  93  83  35 
MCV2          71  82  91  91  99* 
PCV1         
PCV3         
Pol3 2010  76  MICS   70  79  79  89  83  86  86  83  16 
Rota1          68  65 
Rota_last          52  31 
Rubella1          71  82  91 
TT2plus 2010  29  MICS   70  59  66  75  69  77  55  63 
PAB         
VAD1          67  17  66  44  28  49 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Iraq)
BCG 90  90  90  90  92  93  96  76 
DTP1 82  87  90  86  88  92  93  36 
DTP3 68  69  79  74  78  80  83  14 
HepB3 66  61  77  72  75  67 
HepB_BD 43  37  32  27  60 
Hib3 68  36 
MCV 63  69  77  75  81  86  75 
MCV2 57  68  77  77  87 
PAB 72  85  85  80  69  75  70 
PnC3
Pol3 70  70  80  74  78  83  83  16 
Rota_last 52  31 

Number of districts in the country 133  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
99 
   
/
|
|
\
Greater or equal to 90% 16
From 80 to 89% 35
From 50 to 79% 47
Less than 50% 2
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT 2, 4, 6, 18 months; 4-6 years; Yes
DTwPHib 4, 18 months; 4-6 yearrs; Yes
DTwPHibHepB 2, 6 months; Yes
HepB birth; Yes and adults in high risk groups
Influenza High risk groups
MMR 15 months; 4-5 years; Yes
Measles 9 months; Yes
OPV birth; 2, 4, 6, 18 months; Yes
Rotavirus 2, 4, 6 months; Yes
TT 1st contact; +1, +6 months; +1, +1 years; Yes CBAW and PW
Td > 6 years; Yes
Typhoid 4 years; No high risk group
VitaminA 9, 18 months; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2012-2017  2012-2017  2010-2014  2009-2014  2010-2114  2009 - 2013  2008-2012 
Nº of districts with microplans that include activities to raise immunization coverage number 133    129    72  114  70 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes       

System performance

Total Nº districts in country number 133  130  129  125  121  115  114 
Nº districts with DTP3 coverage >=80% number 68  65  98  73  73  70  23 
% of districts with DTP3 coverage >=80% From 0 to 100% 51  50  76  58  60  61  20 
Nº districts with measles (MCV1) coverage >=95% number 15  23  37  39  50  50   
% of districts with MCV1 coverage >=95% From 0 to 100% 11  18  29  31  41  43   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  No         
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes    Yes  Yes  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 100        100  100  100 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.